Stockscreener 앱 받기
19.53
0.46%
0.05
전일 마감가:
$19.48
열려 있는:
$19.47
하루 거래량:
644.67K
Relative Volume:
1.21
시가총액:
$875.75M
수익:
$206.22M
순이익/손실:
$-16.70M
주가수익비율:
-50.60
EPS:
-0.386
순현금흐름:
$-5.55M
1주 성능:
+3.38%
1개월 성능:
+14.85%
6개월 성능:
+26.42%
1년 성능:
+25.13%
1일 변동 폭
$19.32
$20.05
1주일 범위
$18.49
$20.05
52주 변동 폭
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
19.54 | 892.34M | 206.22M | -16.70M | -5.55M | -0.386 |
ABT
Abbott Laboratories
|
116.40 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.25 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.09 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.71 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.86 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 개시 | Citigroup | Buy |
| 2021-03-09 | 재확인 | Needham | Buy |
| 2020-12-16 | 재확인 | Needham | Buy |
| 2020-08-04 | 재확인 | Needham | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 재확인 | Needham | Buy |
| 2020-02-19 | 개시 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | BofA/Merrill | Buy |
| 2018-11-12 | 개시 | Canaccord Genuity | Buy |
| 2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
| 2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
SI-BONE (NASDAQ: SIBN) affiliate plans $110K stock sale - Stock Titan
SI-BONE (NASDAQ: SIBN) officer’s tax sale leaves 130K+ stock units - Stock Titan
SI-BONE (NASDAQ: SIBN) CFO holds 167,604 RSU shares after tax sales - Stock Titan
SI-BONE (NASDAQ: SIBN) trust to sell 51,884 shares of common stock - Stock Titan
Cadian Capital discloses 7.5% SI-BONE (SIBN) ownership in Schedule 13G filing - Stock Titan
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript - AOL.com
(SIBN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
SI-BONE (STU:2K3) Shiller PE Ratio : (As of Aug. 12, 2026) - GuruFocus
SI-BONE (STU:2K3) Cyclically Adjusted Price-to-FCF : (As of Aug. 12, 2026) - GuruFocus
SI-BONE Inc (STU:2K3) Stock News, Headlines & Updates - GuruFocus
Who's Buying or Selling SI-BONE Inc (STU:2K3) Stock Today? - GuruFocus
SI-BONE Inc Stock Baskets - GuruFocus
SI-BONE Inc (STU:2K3) Stock Earnings Transcripts - GuruFocus
SI-BONE Inc (STU:2K3) Stock Price & 30 Year Financial Data - GuruFocus
SI-BONE Inc Stock Operating Data - GuruFocus
SiBone $SIBN Shares Bought by Dimensional Fund Advisors LP - MarketBeat
SI-BONE Inc (SIBN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SiBone (NASDAQ:SIBN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
The SI-BONE, Inc. (NASDAQ:SIBN) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 37.82% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
SiBone $SIBN Shares Purchased by Sei Investments Co. - MarketBeat
Renaissance Technologies LLC Increases Stake in SiBone $SIBN - MarketBeat
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $20 to $27 - Moomoo
BlackRock, Inc. Adds to SI-BONE Inc (SIBN) Stake -- Shares Trade 13% Below GF Value - GuruFocus
SI-BONE, Inc. (SIBN) director sells 20,000 shares after option exercise - stocktitan.net
Canaccord reiterates SI-BONE stock rating on strong Q2 results By Investing.com - Investing.com India
SIBN Maintained by UBS -- Price Target Raised to $25 - GuruFocus
SI BONE : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
SI-BONE, Inc. 2026: Revenue $56.01M, EPS ($0.09) — 10-Q Summary - TradingView
SIBN Maintained by TD Cowen -- Price Target Raised to $20.00 - GuruFocus
SiBone's (SIBN) Buy Rating Reaffirmed at Truist Financial - MarketBeat
UBS Lifts Price Target on SI-BONE to $25 From $24, Maintains Buy Rating - marketscreener.com
SI-BONE, Inc. Stock 12‑Month Price Target Raised to $25, Implies 36% Upside - TradingView
Canaccord reiterates SI-BONE stock rating on strong Q2 results - Investing.com Nigeria
SI-BONE, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Truist Adjusts Price Target on SI-BONE to $23 From $21, Maintains Buy Rating - marketscreener.com
SIBN Looks 10.6% Undervalued on GF Value™ Amid Strong Growth Pro - GuruFocus
SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Re - GuruFocus
SIBN Looks 10.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Earnings call transcript: SI-BONE tops Q2 2026 estimates, shares fall after hours - Investing.com Nigeria
SIBN Q2 FY2026 earnings call - finance.biggo.com
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance Singapore
SiBone Q2 Earnings Call Highlights - MarketBeat
Earnings Flash (SIBN) SI-BONE Posts Q2 Loss $0.09 per Share, vs. FactSet Est of $0.15 Loss - marketscreener.com
SI-BONE Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (SIBN) SI-BONE, Inc. Reports Q2 Revenue $56.0M, vs. FactSet Est of $55.3M - marketscreener.com
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance - The Manila Times
SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook - TradingView
SI-BONE Reports Q2 2026: $56.0M Revenue, Positive Adjusted EBITDA of $2.8M, Raises 2026 Revenue Guidance - TradingView
BRIEF-SI-BONE Q2 Revenue USD 56.01 Million Vs. IBES Estimate USD 55.3 Million - TradingView
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.36%
0.01%
자본화:
|
볼륨(24시간):